Sie sind auf Seite 1von 3

.-.:Pt;A LrrUdS - Med-liurd t.;ere .

Drug Name

4#.friy}r \
.HYURUmOrpnOne PGA

.;oncentrafions:
i0mg/30m1
(1

mg/mL)

\-_,,-/ Min
Soft Mln I nla ,CA Pause Protocol:
rlo

opioid

NAIVE

:onM
Limits
)CA Dose lontinuous Dose /

-/

Conc, Units I nla Haro 5()II Soft


Min Min
0.'t
0.1 u.1

Hard Hard Max


0.6

I
lnitial

Soft Max
n/a

nla
Value

Max

lolus Dose
-oadino Dose -ockout lnterval (minutes)

nla nla nla nla


6

)oslng Units
nd

0.8

2 2

u,z
60

nla nla

iltax Accum. lncludes Bolus?


rlo

nla

)linica! Advisory Name

lN double check UCH

B66dl rqtB f.lOT rer*mmend*d ift stli*id nake


nilr&Bnru!

PBliEnt C(nt(lled AnBlgr$i, (M FCA) D0tlng Ouide morchlns rn Ns (oploid N lvE) rcA htuslon 150 mgl30 mL (5

''.r:

mghl)
mL

til r"r'ix,t.r'

?'il'',',:

iqFYDRomo$hone

is lO #ar.NM.b

iiNg (ortotd r{rS\G) PcAlntusion 30 m!/30 r(r*1ii{r}s.i:Qfiitilllur.Slsinrll:*s*1isi ro*1ii{r}s.i:Qfiitilllur.Slsinrll:*s*1isi


l",iroi'.ne

(l mdmu

#.#;Y.Y,W! .

. -&ffiSSSffi# r?1*".*.1ffi .o...,,-," .- N##ei. Effi!:G


r ffir

ire;

t/#di.d.{iii:$li1u.

ll

PCA Druqs - Critical Care

Drug Name Therapy


.HYDROmorphone PCA opioid TOLERANT

)oncentrations:

l0mg/30m1

(1

mg/mL)

)oncentration Limits Limits


)CA Dose )onlinuous Dose i

Conc. Unlts nla son Hard Soft


Mln Mln
0.'1 0.'1

Hard Min

Soft Min
n/a

nla
Haro Max
5 5

Soft Max nla

Max
3 3 3

lnrtlat Value

,CA Pause Protocol: {o

Jolus Dose oadinq Dose .ockout lnterval (minutes) /lax Acc. Dose Range / 4 h

nla nla nla nla

)osing Units
nd

0.'l 0.'l

6 6

nla nla

flax Accum. lncludes Bolus? {o

I
nla

60

nla

)linical Advisory Name lN double check UCH

PGA DmqS - MeO-sUrq Gare

Drug Name

)oncentrations'
l0mg/30m1
(1

f .HYDROmorphone PCA \oprord T0LERANT


,'oncentration Limits Limits
,CA Dose )ontinuous Dose /

---?lrrryY_-\

mg/mL)

Conc. Units
nla Haro Min

Hard Min

nla

Soft Min nla

Soft Max nla

soII
Min
0.1 0.1

soft
Max
3 3 3 3

Hard Max
5
5

lnitial
Value

,CA Pause Protocol:


,lo

lolus Dose
-oadino Dose nnknr rt lntarual /mint fec\ /lax Acc. Dose Range / 4 h

nla nla nla nla

)oslng Units
nd

0.'l
0.1

6
6

nle nla

llax Accum. lncludes Bolus?


,1rl

60

nla

)linical Advisory Name


tN double check UCH

nla

12

urug Name
Therapy PalliaflveGare/oNg .HYDRomorphone

PcA Druos - Critical Gare ]oncentrations: 100 mg / 30 mL (10 mg / mL)

]oncentration Limits
Limits
)CA Dose lontinuous Dose /

Conc. Units I nla 5()n Hard 5olt


Min Min
z.
'4.

Hard Hard Max


30 30 30
30

Min

I
lnitial

nla
Value

Soft Min I nla )CA Pause Protocol:


tlo

Soft Max nla

Max
20 20 20 20 60

lolus Dose
-oadinq Dose -ockout lnterval (minutes) r'lax Acc. Dose Range / 4

nla nla nla nla


8
h

)osing Units
nn

2.5 2.5

nla nla
10

Ulax

Accum. lncludes Bolus?

{o

nla

llinical Advlsory Name


)all Care/ONC PCA

nla
PGA Druq6 - Med-SurE Care

Drug Name

Jffi

:oncentrations' \
100 mg

/ 30 mL (10 mg / mL)

a .HYDRomorphone -\--#-;oncenlraflon Ltmlts


Limits
)CA Dose lontinuous Dose /

4allialivecare/oNG

Conc. Uirits nla


Hato Min
DOII

Hard Hard Max


30 30 30 30

Min

I
lnitial

nla
Value

soft
Max
20 20 20 20 60

Min
2.5 2,5

Sott lvlin I nla ,CA Pause Protocol: {o

Soft Max
nla

lolus Dose
oadino Dose ockout lnterval /minutes)
y'lax

nla nla nla nla


8 h

)osing Units
no

z.c
2.5

nla nla
10

l,Iax

Accum. lncludes Bolus?

{o

nla

llinical Advisory Name


)all Care/ONC PCA

Acc. Dose Range / 4

nla

i6'"v,.n!(

p,rionr r:odErllr{ nr"li}4rd

fl( Pc,i lririrn

s,[4

S\N.lritl
I

i$$(r'ri,,,l
'

ll I

lll

t3

Das könnte Ihnen auch gefallen